Artificial Intelligence For Drug Discovery, Biomarker Development Q2 2018

Posted by bharatbook98 on August 23rd, 2018

Bharat Book Bureau Provides the Trending Market Research Report on “Artificial Intelligence For Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2 2018”under  Life Sciences   category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Artificial Intelligence For Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2/2018 offers comprehensive coverage of the current state of the AI in Drug Discovery industry landscape, featuring chapters on the history, current state and near future of the industry, regional and subsector-specific competutive and comparative analyses, and profiles of 100 Companies, 220 Investors, 15 Biopharma, 15 IT/Tech Corporations, and 20 leading R&D Centres active in the AI for Drug Discovery space.

Section I delivers a summary of the most important recent industry events, including coverage of the most important BioPharma and IT/Tech corporations active in the space, government initiatives aiming to accelerate the dynamic of industry progress in the USA, UK, EU and Asia-Pacific region, industry-specific conferences and journalists, and a regional comparison of industry activity that summarizes which countries are currently at the forefront of activity, which ones are lagging behind, and which ones are showing evidence of rapidly increasing activity in the years to come.

Request a free sample copy of Artificial Intelligence For Drug Discovery Market Report @ https://www.bharatbook.com/MarketReports/Sample/Reports/1211205

Section II provides in-depth coverage of the science and technology behind the industry, analysis of emerging subsectors and new application within the industry (including the convergence of AI with blockchain, digital medicine and Longevity technologies), and finally, a near-future forecast of industry growth and diversification from 2019 to 2020.

Section III: Comparative Industry Analysis & Classification Framework (Investor and M&A Guide), 70 pages in length, a section specifically tuned to industry professionals such as investors, analysts, BioPharma/Tech executives and decision-makers, is available for purchase. This section is devoted to an in-depth comparative and quantitative analysis of the entire AI for Drug Discovery landscape, utilizing advanced infographics and tangible parameters both for

(1) ranking various AI for Drug Discovery companies according to their levels of scientific validation, clinical development, R&D and industry-application diversification, and overall prospects for future growth and for

(2) classifying AI for Drug Discovery companies according to their type and number of distinct industry applications, proportion of AI specialists, number of patents and publications, use of next-generation AI technologies (e.g. GANs vs ML), and whether they utilize AI as a core component of their R&D or as a complementary element to enhance their primary, non-AI focus and business model.

Browse our full report with Table of Contents : https://www.bharatbook.com/MarketReports/Artificial-Intelligence-For-Drug-Discovery-Biomarker-Development-and-Advanced-RD-Landscape-Overview-Q2-2018/1211205

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn, Google Plus

Link To Directory
Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members

Copyright 2019 Uberant.com
595,127 total articles and counting.